Voluntary Scheme for Branded Medicines Pricing and Access

(asked on 17th October 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Voluntary scheme for branded medicines pricing and access, whether her Department has made an assessment of the potential merits of an exemption from payments for new active substances from that scheme.


Answered by
Robert Jenrick Portrait
Robert Jenrick
Shadow Secretary of State for Justice
This question was answered on 25th October 2022

The Voluntary Scheme for Branded Medicines Pricing and Access includes a 36 month exemption from payments for drugs containing a new active substance, starting once the marketing authorisation has been granted. Treatment of new active substances under a future voluntary scheme is subject to negotiation.

Reticulating Splines